Navigation Links
Poor footwear linked to foot impairment and disability in gout patients
Date:10/2/2011

New research shows that use of poor footwear is common among patients with gout. According to the study published today in Arthritis Care & Research, a peer-reviewed journal of the American College of Rheumatology (ACR), gout patients who make poor footwear choices experienced higher foot-related pain, impairment and disability. Gout patients also reported that comfort, fit, support and cost were the most important factors for selecting footwear.

Gout is a type of inflammatory arthritis caused by the crystallization of uric acid within the joints and other tissues. Those with gout experience severe pain and swelling, with the majority of cases affecting the feet. A study published last month in the ACR journal, Arthritis & Rheumatism, shows that doctor-diagnosed gout has risen over the past twenty years and now affects 8.3 million individuals in the U.S. Previous studies have shown that chronic gout contributes to changes in patients' gait parameters, which is consistent with pain avoidance strategy, and likely leads to impaired foot function.

A research team led by Professor Keith Rome from AUT University in Auckland, New Zealand, recruited 50 patients with a history of gout from local rheumatology clinics. Researchers assessed clinical disease characteristics, overall function, foot impairment and disability. The type of footwear worn by patients and factors associated with patient choice of footwear were also evaluated. To determine the suitability of footwear, the team used criteria gauging the adequacy of the footwear from a previous rheumatoid arthritis foot pain study.

"We found that gout patients in our study often wore improper footwear and experienced moderate to severe foot pain, impairment and disability," explains Professor Rome. Roughly 56% of patients made good footwear choices by wearing walking shoes, athletic sneakers, or oxfords. Of the remaining patients, 42% wore footwear that are considered poor and included sandals, flip-flops, slippers, or moccasins; 2% wore boots which are considered average; and none wore high-heeled shoes.

Characteristics of poor footwear included improper cushioning, lack of support, as well as inadequate stability and motion control. Those gout patients who wore poor shoes or sandals reported higher foot-related impairment and disability. More than half of all participants wore shoes that were 12 months or older and showed excessive wear patterns. Factors study participants identified as important for selecting footwear included comfort (98%), fit (90%), support (79%), and cost (60%).

"We found gout patients in our study wore footwear that lacked cushioning, control and stability," concluded Professor Rome. "Many patients' shoes also showed excessive wear and we suggest that proper footwear selection be discussed with gout patients to reduce foot pain and impairment." The authors suggest that further research assessing economically-priced footwear with ample cushioning, adequate motion control and sufficient forefoot width is needed.


'/>"/>

Contact: Dawn Peters
healthnews@wiley.com
781-388-8408
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Payless ShoeSource Democratizes Health and Wellness With Launch of Champion Fitness Toning Footwear for Women
2. Five Essential Steps to Choosing Toning Footwear
3. Molecular pathways linked to sex, age affect outcomes in lung cancer
4. Physical Changes in Brain Linked to Altered Spirituality
5. Migraine Linked to Increased Heart Attack Risk
6. First Gene Variants Linked to Stuttering Discovered
7. Flat Head Syndrome Linked to Developmental Delays
8. Untreated poor vision in elderly linked to dementia, University of Michigan study shows
9. Genetic Mutation Linked to Prostate Cancer in Blacks
10. Sleep More, Lose Weight – Sleeplessness Linked to Obesity
11. Antibodies linked to cardiovascular disease increase in patients with active lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... ... (ONS) wanted to create a communications platform that positions them as the go-to ... and ONS reinvented their online publication as an always-on, always-fresh news, views and ...
(Date:3/24/2017)... ... March 24, 2017 , ... The law firm of ... is pleased to announce Westchester resident Lauren C. Enea has joined the firm as ... firm, will concentrate her practice in elder law, Medicaid planning and applications, and Wills, ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, ... their training and leads programs. , In February, 2017, Empower Brokerage introduced their ... Performance Partners is designed to teach how to maximize their sales efforts, as ...
(Date:3/24/2017)... ... 2017 , ... “End Time GPS”: a dauntless and enlightened study of ... GPS” is the creation of published author, Wesley Gerboth, a World War II veteran, ... space-vehicle projects. Now, at age ninety-one, he shares the Wisdom God bestowed upon him ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Adventures of Joey, The Dog ... dog who lives his life to the fullest, as God intended. “The Adventures of ... Holmgren, a mother and grandmother pursuing her passion for writing, especially about truth and ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)...   The Accreditation Council for Medical Affairs ... the pharmaceutical industry has appointed Dr. Jane ... formed scientific advisory board. Dr. Chin will be ... ever medical affairs think tank within the pharmaceutical ... ACMA, please visit  www.medicalaffairsspecialist.org .  Connect with ...
(Date:3/24/2017)... FinancialBuzz.com News Commentary  ... According to new data published Arcview ... legal cannabis market is projected to continue to grow at ... the current presidential administration. The report created by Arcview,s data ... growth in this industry are the passage and subsequent implementation ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of the ... their offering. ... pipeline is very strong with a total of 97 drug candidates. Pharma ... Sanofi are involved in the development of the IPF therapeutics. The IPF ... III stage, 15 are in Phase II stage, 12 are in Phase ...
Breaking Medicine Technology: